Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corticosteroid therapy in older adults with cancer: Expert recommendations from a task force of the International Society of Geriatric Oncology.

Journal of geriatric oncology·2024
Same author

Impact of an early geriatric rehabilitation program in acutely hospitalised vulnerable patients: a real-life study in an ACE unit in Switzerland.

Geriatrie et psychologie neuropsychiatrie du vieillissement·2023
Same author

Impact of Pharmaceutical Interventions with STOPP/START and PIM-Check in Older Hospitalized Patients: A Randomized Controlled Trial.

Drugs & aging·2022
Same author

Influenza vaccination reduces dementia risk: A systematic review and meta-analysis.

Ageing research reviews·2021
Same author

Ability to detect potentially inappropriate prescribing in older patients: comparative analysis between PIM-Check and STOPP/STARTv2.

European journal of clinical pharmacology·2021
Same author

Statin (mis)use in older people: A cross-sectional study using French health insurance databases.

Pharmacoepidemiology and drug safety·2021

Related Experiment Video

Updated: Jun 19, 2026

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
07:27

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK

Published on: December 18, 2012

Stop shingles in its tracks.

Pierre-Olivier Lang1, Yasmine Hasso, Jean Pierre Michel

  • 1University Hospitals and Medical School of Geneva, Thonex-Geneva, Switzerland. pierre.o.lang@hcuge.ch

The Journal of Family Practice
|October 31, 2009
PubMed
Summary
This summary is machine-generated.

Early antiviral treatment for herpes zoster (HZ) within 72 hours improves outcomes and reduces postherpetic neuralgia (PHN). Vaccination is recommended for adults 60 and older to prevent HZ and PHN.

More Related Videos

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
07:10

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

Published on: August 15, 2025

Quantitative Fluorescence In Situ Hybridization (FISH) and Immunofluorescence (IF) of Specific Gene Products in KSHV-Infected Cells
06:21

Quantitative Fluorescence In Situ Hybridization (FISH) and Immunofluorescence (IF) of Specific Gene Products in KSHV-Infected Cells

Published on: August 27, 2019

Related Experiment Videos

Last Updated: Jun 19, 2026

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
07:27

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK

Published on: December 18, 2012

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
07:10

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

Published on: August 15, 2025

Quantitative Fluorescence In Situ Hybridization (FISH) and Immunofluorescence (IF) of Specific Gene Products in KSHV-Infected Cells
06:21

Quantitative Fluorescence In Situ Hybridization (FISH) and Immunofluorescence (IF) of Specific Gene Products in KSHV-Infected Cells

Published on: August 27, 2019

Area of Science:

  • Infectious Diseases
  • Immunology
  • Dermatology

Background:

  • Herpes zoster (HZ), commonly known as shingles, is a viral infection caused by the reactivation of the varicella-zoster virus.
  • Postherpetic neuralgia (PHN) is a common and often debilitating complication of HZ, characterized by persistent nerve pain.
  • Current management strategies for HZ focus on antiviral therapy and pain management, with vaccination emerging as a key preventive measure.

Purpose of the Study:

  • To outline optimal management strategies for acute herpes zoster.
  • To emphasize the importance of timely antiviral intervention for reducing pain and preventing complications like PHN.
  • To highlight the role of herpes zoster vaccination in primary prevention.

Main Methods:

  • Review of clinical guidelines and evidence-based practices for herpes zoster management.
  • Analysis of treatment efficacy regarding the timing of antiviral initiation.
  • Assessment of herpes zoster vaccine effectiveness in reducing disease incidence and severity.

Main Results:

  • Initiating antiviral treatment within 72 hours of HZ outbreak significantly increases the likelihood of rapid pain resolution and reduces the incidence of PHN.
  • Herpes zoster vaccination is highly effective in reducing the overall incidence of HZ and the subsequent development of PHN in individuals aged 60 and older.
  • The use of tricyclic antidepressants and corticosteroids is not recommended during the acute phase of HZ.

Conclusions:

  • Prompt antiviral therapy is crucial for managing acute herpes zoster and mitigating the risk of PHN.
  • Herpes zoster vaccination represents a vital preventive strategy for older adults, significantly lowering disease burden.
  • Adherence to recommended treatment and prevention guidelines can improve patient outcomes and quality of life.